BioXcel Therapeutics
BTAI
BTAI
117 hedge funds and large institutions have $567M invested in BioXcel Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 30 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 108 → 117 (+9)
0.17% less ownership
Funds ownership: 3.32% → 3.15% (-0.17%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
117
Holding in Top 10
–
Calls
$28.8M
Puts
$11.9M
Top Buyers
| 1 | +$17.6M | |
| 2 | +$4.48M | |
| 3 | +$4.39M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$4.35M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$4.19M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$8.61M | |
| 3 | -$5.54M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.6M |
| 5 |
Jane Street
New York
|
-$2.08M |